pSS HC
Number 31 29
Age(years) 47.13±11.94 43.69±8.79
Female,n(%) 29(93.55%) 28(96.55%)
Male,n(%) 2(6.45%) 1(3.45%)
Disease duration(months) 46(1-122) NA
Major clinical features
Dry mouth,n(%) 24( 77.42%) NA
Dry eye,n(%) 15(48.39%) NA
Decayed tooth,n(%) 11(35.48%) NA
Glandular swelling,n(%) 5(16.13%) NA
Raynaud’s phenomenon,n(%) 3(9.68%) NA
Fatigue,n(%) 15(48.39%) NA
Weigh loss,n(%) 1(3.23%) NA
Arthralgia,n(%) 9(29.03%) NA
Skin involvement,n(%) 6(19.35%) NA
Primary biliary cirrhosis,n(%) 5(16.13%) NA
Renal involvement,n(%) 4(12.90%) NA
Interstitial lung disease,n(%) 11(35.48%) NA
Fever,n(%) 1(3.23%) NA
Muscle involvement,n(%) 1(3.23%) NA
Nervous system involvement,n(%) 1(3.23%) NA
High-IgG 20(64.52%) NA
Leukocytopenia 5(16.13%) NA
Major laboratory features
ESR(mm/h) 14.50(2.00-62.00) NA
CRP(mg/L) 1.76(0.20-8.91) NA
RF(IU/ml) 46.20(20.00-777.00) NA
WBC(×109/L) 4.72(2.79-11.78) NA
Lymphocyte(×109/L) 1.55±0.60 NA
NC(×109/L) 2.69(1.44-8.74) NA
RBC(×1012/L) 4.23±0.38 NA
Hb(g/L) 126±11.26 NA
Plt(×109/L) 203.80±49.31 NA
Serum globulin(g/L) 31.70±6.13 NA
IgG(g/L) 17.84±5.01 NA
IgA(g/L) 2.77(1.40-10.60) NA
IgM(g/L) 1.16(0.41-7.35) NA
C3(g/L) 0.79 (0.62-1.52) NA
C4(g/L) 0.19±0.06 NA
Anti-SSA/Ro52 (+) ,n(%) 28(90.32%) NA
Anti-SSA/Ro60 (+),n(%) 24(77.42%) NA
Anti-SSB(+),n(%) 20(64.52%) NA
Anti-centromere(+),n(%) 3(9.68%) NA
ESSDAI 3.00(1.00-8.00) NA
ESSPRI 3.00(1.33-5.00) NA
ILD: Interstitial lung disease , PBC:Primary biliary cirrhosis ESR:Erythrocyte Sedimentation Rate, ILD: Interstitial lung disease , PBC:Primary biliary cirrhosis ESR:Erythrocyte Sedimentation Rate, ILD: Interstitial lung disease , PBC:Primary biliary cirrhosis ESR:Erythrocyte Sedimentation Rate,
RF: Rheumatoid Factor, CRP:C-Reactive Protein, WBC: White Blood Cell, RF: Rheumatoid Factor, CRP:C-Reactive Protein, WBC: White Blood Cell, RF: Rheumatoid Factor, CRP:C-Reactive Protein, WBC: White Blood Cell,
RBC: Red Blood Cell , Hb: Hemoglobin, Plt :Platelet, NC: Neutrophil Cell, RBC: Red Blood Cell , Hb: Hemoglobin, Plt :Platelet, NC: Neutrophil Cell, RBC: Red Blood Cell , Hb: Hemoglobin, Plt :Platelet, NC: Neutrophil Cell,
IgG: Immunoglobulin G, IgA: Immunoglobulin A, IgM: Immunoglobulin M, IgG: Immunoglobulin G, IgA: Immunoglobulin A, IgM: Immunoglobulin M, IgG: Immunoglobulin G, IgA: Immunoglobulin A, IgM: Immunoglobulin M,
C3: Complement 3, C4: Complement 4, NA: Not Applicable, C3: Complement 3, C4: Complement 4, NA: Not Applicable, C3: Complement 3, C4: Complement 4, NA: Not Applicable,
ESSDAI:European League Against Rheumatism Sjogren’s Syndrome Disease Activity Index, ESSDAI:European League Against Rheumatism Sjogren’s Syndrome Disease Activity Index, ESSDAI:European League Against Rheumatism Sjogren’s Syndrome Disease Activity Index,
ESSPRI:European League Against Rheumatism Sjogren’s Syndrome Patient Reported Index. ESSPRI:European League Against Rheumatism Sjogren’s Syndrome Patient Reported Index. ESSPRI:European League Against Rheumatism Sjogren’s Syndrome Patient Reported Index.